Enzyme inhibitors and enzyme substrates

TDZD-8(NP 01139) is a selective inhibitor of GSK-3, a thiadiazolidinone derivative, non-ATP competitive inhibitor of GSK-3β (IC50 = 2 μM): does not inhibit Cdk-1/cyclin B, CK-II, PKA or PKC at &gt:100 μM.TDZD-8 has been used to study the role of

TDZD-8(NP 01139) is a selective inhibitor of GSK-3, a thiadiazolidinone derivative, non-ATP competitive inhibitor of GSK-3β (IC50 = 2 μM): does not inhibit Cdk-1/cyclin B, CK-II, PKA or PKC at &gt:100 μM.TDZD-8 has been used to study the role of

Temsirolimus (CCI-779) directly inhibits mTOR kinase activity with IC50 values of 1.76 ± 0.15 μM.A potent inhibitor of FRAP (mTOR) kinase activityapplication：Temsirolimus is used as a rapamycin derivative with anti-cancer activity that inhibits

Temsirolimus (CCI-779) directly inhibits mTOR kinase activity with IC50 values of 1.76 ± 0.15 μM.A potent inhibitor of FRAP (mTOR) kinase activityapplication：Temsirolimus is used as a rapamycin derivative with anti-cancer activity that inhibits

Temsirolimus (CCI-779) directly inhibits mTOR kinase activity with IC50 values of 1.76 ± 0.15 μM.A potent inhibitor of FRAP (mTOR) kinase activityapplication：Temsirolimus is used as a rapamycin derivative with anti-cancer activity that inhibits

Reverse transcriptase inhibitor.

Reverse transcriptase inhibitor.

Reverse transcriptase inhibitor.

Reverse transcriptase inhibitor.

Reverse transcriptase inhibitor.

Tetramisole hydrochloride is suitable for inhibition of various alkaline phosphatase (i.e., liver, kidney, placenta, bone and tumor)(Intestinal alkaline phosphatases are only slightly inhibited.).

Tetramisole hydrochloride is suitable for inhibition of various alkaline phosphatase (i.e., liver, kidney, placenta, bone and tumor)(Intestinal alkaline phosphatases are only slightly inhibited.).